# Enoxamed Study in the Treatment of Acute Coronary Syndromes

> **NCT02152423** · PHASE1 · COMPLETED · sponsor: **University of Monastir** · enrollment: 50 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** LOVENOX
- **DRUG:** ENOXAMED

## Key facts

- **NCT ID:** NCT02152423
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02152423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02152423, "Enoxamed Study in the Treatment of Acute Coronary Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02152423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*